Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc.https://investorshangout.com/Aldeyra-Therapeutics-Inc-ALDX-92876/en-usFri, 16 Oct 2026 14:53:35 GMTCopyright InvestorsHangout.comJGrabar: ATTENTION LONG-TERM ALDEYRA THERAPEUTICS, INC. (NASDAQ: ALDX) INVESTORS Grabar Law Office is investhttps://investorshangout.com/post/view?id=6683783https://investorshangout.com/post/view?id=6683783Thu, 11 Apr 2024 16:29:49 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Dhttps://investorshangout.com/post/view?id=6647318https://investorshangout.com/post/view?id=6647318Mon, 27 Nov 2023 21:15:48 GMTznewcar1: $ALDX 23% v3,8M C2.77 f58,822M Hod2.77 ML1.42https://investorshangout.com/post/view?id=6641830https://investorshangout.com/post/view?id=6641830Wed, 08 Nov 2023 02:49:30 GMTwhytestocks: $ALDX News Article - Invest In Penny Stocks? Is It Worth It & 4 To Watch Now https://investorshangout.com/post/view?id=6641708https://investorshangout.com/post/view?id=6641708Tue, 07 Nov 2023 19:25:48 GMTwhytestocks: $ALDX News Article - What's Going On With Aldeyra Therapeutics Stock? | Benzinga https://investorshangout.com/post/view?id=6639635https://investorshangout.com/post/view?id=6639635Wed, 01 Nov 2023 16:05:47 GMTwhytestocks: $ALDX News Article - FRIDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Aldeyra Thttps://investorshangout.com/post/view?id=6622665https://investorshangout.com/post/view?id=6622665Tue, 26 Sep 2023 18:30:51 GMTwhytestocks: $ALDX News Article - NASDAQ: ALDX Lawsuit Alert: Investors who lost over $100,000 with shares of Aldhttps://investorshangout.com/post/view?id=6608443https://investorshangout.com/post/view?id=6608443Tue, 15 Aug 2023 16:10:47 GMTwhytestocks: $ALDX News Article - ALDX Stock News: Shareholders with Significant Losses in Aldeyra Therapeutics, https://investorshangout.com/post/view?id=6607208https://investorshangout.com/post/view?id=6607208Fri, 11 Aug 2023 19:30:46 GMTwhytestocks: $ALDX News Article - INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Aldeyra Therhttps://investorshangout.com/post/view?id=6604727https://investorshangout.com/post/view?id=6604727Fri, 04 Aug 2023 19:30:53 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics to Participate in SVB Securities Therapeutics Forum https://investorshangout.com/post/view?id=6593225https://investorshangout.com/post/view?id=6593225Thu, 06 Jul 2023 12:10:49 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Linehttps://investorshangout.com/post/view?id=6590871https://investorshangout.com/post/view?id=6590871Wed, 28 Jun 2023 20:11:37 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Announces Achievement of Statistical Significance for Primhttps://investorshangout.com/post/view?id=6586134https://investorshangout.com/post/view?id=6586134Thu, 15 Jun 2023 14:05:46 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Completes Enrollment in Phase 3 INVIGORATE-2 Clinical Triahttps://investorshangout.com/post/view?id=6560795https://investorshangout.com/post/view?id=6560795Thu, 13 Apr 2023 18:40:56 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Inc. (NASDAQ: ALDX) Records 52-Week High Monday Morning https://investorshangout.com/post/view?id=6558813https://investorshangout.com/post/view?id=6558813Mon, 10 Apr 2023 17:45:47 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporhttps://investorshangout.com/post/view?id=6546474https://investorshangout.com/post/view?id=6546474Thu, 09 Mar 2023 16:40:47 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Submits New Drug Application to the U.S. Food and Drug Admhttps://investorshangout.com/post/view?id=6513503https://investorshangout.com/post/view?id=6513503Wed, 21 Dec 2022 16:25:50 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Announces Oral Presentation of Phase 3 Data at the Americahttps://investorshangout.com/post/view?id=6489840https://investorshangout.com/post/view?id=6489840Wed, 26 Oct 2022 17:20:54 GMTAviseAnalytics: Will Aldeyra Hit the Bull’s Eye in Dry Eye? $ALDX Excited to share our latest chttps://investorshangout.com/post/view?id=6439867https://investorshangout.com/post/view?id=6439867Tue, 19 Jul 2022 12:19:59 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Achieves Primary Endpoints in Dry Eye Disease Chamber Croshttps://investorshangout.com/post/view?id=6436605https://investorshangout.com/post/view?id=6436605Tue, 12 Jul 2022 14:40:54 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Global Hehttps://investorshangout.com/post/view?id=6418328https://investorshangout.com/post/view?id=6418328Thu, 09 Jun 2022 16:05:54 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Linehttps://investorshangout.com/post/view?id=6417039https://investorshangout.com/post/view?id=6417039Tue, 07 Jun 2022 20:15:57 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Announces Chief Financial Officer Transition https://investorshangout.com/post/view?id=6392699https://investorshangout.com/post/view?id=6392699Thu, 28 Apr 2022 20:25:52 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics to Announce Top-Line Data for Systemic RASP Modulator ADX-https://investorshangout.com/post/view?id=6371962https://investorshangout.com/post/view?id=6371962Tue, 29 Mar 2022 12:45:55 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporhttps://investorshangout.com/post/view?id=6364916https://investorshangout.com/post/view?id=6364916Thu, 17 Mar 2022 17:00:54 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Initiates Phase 2 Clinical Trial of ADX-2191 for the Treathttps://investorshangout.com/post/view?id=6357924https://investorshangout.com/post/view?id=6357924Tue, 08 Mar 2022 13:55:54 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Reports Third-Quarter 2021 Financial Results and Recent Cohttps://investorshangout.com/post/view?id=6272174https://investorshangout.com/post/view?id=6272174Thu, 28 Oct 2021 16:25:55 GMTznewcar1: ALDX 33% v83,6 c14.85 f47,5M H15.95https://investorshangout.com/post/view?id=6119519https://investorshangout.com/post/view?id=6119519Tue, 27 Apr 2021 21:37:45 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics, Inc. Announces Proposed $125 Million Public Offering of Chttps://investorshangout.com/post/view?id=6119445https://investorshangout.com/post/view?id=6119445Tue, 27 Apr 2021 20:05:49 GMTwhytestocks: $ALDX News Article - Why Aldeyra Therapeutics Stock Is Soaring Today https://investorshangout.com/post/view?id=6119038https://investorshangout.com/post/view?id=6119038Tue, 27 Apr 2021 15:25:48 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Achieves Statistical Significance for Primary Endpoint andhttps://investorshangout.com/post/view?id=6118931https://investorshangout.com/post/view?id=6118931Tue, 27 Apr 2021 14:25:48 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Linehttps://investorshangout.com/post/view?id=6118333https://investorshangout.com/post/view?id=6118333Mon, 26 Apr 2021 20:30:53 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Designhttps://investorshangout.com/post/view?id=6042314https://investorshangout.com/post/view?id=6042314Thu, 04 Feb 2021 20:47:36 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics to Participate in Fireside Chat at the H.C. Wainwright Biohttps://investorshangout.com/post/view?id=6012438https://investorshangout.com/post/view?id=6012438Fri, 08 Jan 2021 16:10:48 GMTznewcar1: ALDX 26% v3,9M c8.47 f38,8M H8.54https://investorshangout.com/post/view?id=6011661https://investorshangout.com/post/view?id=6011661Thu, 07 Jan 2021 22:19:49 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from https://investorshangout.com/post/view?id=6011185https://investorshangout.com/post/view?id=6011185Thu, 07 Jan 2021 17:20:51 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Announces Confirmation of Antiviral Activity of ADX-1612 https://investorshangout.com/post/view?id=5997474https://investorshangout.com/post/view?id=5997474Tue, 22 Dec 2020 13:40:49 GMTwhytestocks: $ALDX News Article - Why Aldeyra Therapeutics Stock Soared Today https://investorshangout.com/post/view?id=5933059https://investorshangout.com/post/view?id=5933059Fri, 16 Oct 2020 20:35:55 GMTwhytestocks: $ALDX News Article - Aldeyra to Present at Cantor and H.C. Wainwright Virtual Investor Conferences https://investorshangout.com/post/view?id=5889199https://investorshangout.com/post/view?id=5889199Thu, 10 Sep 2020 12:20:46 GMTznewcar1: ALDX 21% v4,7M c5.70 f29,7M H6.05 S5.4https://investorshangout.com/post/view?id=5826746https://investorshangout.com/post/view?id=5826746Wed, 15 Jul 2020 01:04:33 GMTwhytestocks: $ALDX bears and bulls https://investorshangout.com/post/view?id=5785520https://investorshangout.com/post/view?id=5785520Wed, 03 Jun 2020 14:25:48 GMTznewcar1: ALDX 20% v1,6M c4.50 f29,7M H4.78 S4.48https://investorshangout.com/post/view?id=5770234https://investorshangout.com/post/view?id=5770234Sun, 17 May 2020 17:09:16 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide Third-Quahttps://investorshangout.com/post/view?id=5580748https://investorshangout.com/post/view?id=5580748Fri, 01 Nov 2019 15:11:49 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics to Present at Ophthalmology Innovation Summit at American https://investorshangout.com/post/view?id=5557871https://investorshangout.com/post/view?id=5557871Mon, 07 Oct 2019 12:50:43 GMTwhytestocks: $ALDX News Article - Aldeyra Therapeutics to Present at 2019 Cantor Global Healthcare Conference https://investorshangout.com/post/view?id=5548178https://investorshangout.com/post/view?id=5548178Wed, 25 Sep 2019 15:10:42 GMTwhytestocks: $ALDX News Article - Medical Device Industry Revenues Should Outpace Healthcare Field https://investorshangout.com/post/view?id=5393833https://investorshangout.com/post/view?id=5393833Wed, 27 Mar 2019 12:35:47 GMTznewcar1: ALDX 35% v21,7M c9.71 f27,395,425 Gap up H12.40 and slide downhttps://investorshangout.com/post/view?id=5393572https://investorshangout.com/post/view?id=5393572Wed, 27 Mar 2019 02:37:38 GMT